|
Originally published In Press as doi:10.1074/jbc.M605536200 on September 1, 2006
J. Biol. Chem., Vol. 281, Issue 44, 33487-33496, November 3, 2006
Canonical Transient Receptor Potential Channels Promote Cardiomyocyte Hypertrophy through Activation of Calcineurin Signaling*
Erik W. Bush 1,
David B. Hood ,
Philip J. Papst ,
Joseph A. Chapo ,
Wayne Minobe ,
Michael R. Bristow ,
Eric N. Olson¶2, and
Timothy A. McKinsey 3
From the
Myogen, Inc., Westminster, Colorado 80021, the Division of Cardiology, University of Colorado Health Sciences Center, Denver, Colorado 80262, and the ¶University of Texas Southwestern Medical Center, Dallas, Texas 75390
The calcium/calmodulin-dependent phosphatase calcineurin plays a central role in the control of cardiomyocyte hypertrophy in response to pathological stimuli. Although calcineurin is present at high levels in normal heart, its activity appears to be unaffected by calcium during the course of a cardiac cycle. The mechanism(s) whereby calcineurin is selectively activated by calcium under pathological conditions has remained unclear. Here, we demonstrate that diverse signals for cardiac hypertrophy stimulate expression of canonical transient receptor potential (TRPC) channels. TRPC consists of a family of seven membrane-spanning nonselective cation channels that have been implicated in the nonvoltage-gated influx of calcium in response to G protein-coupled receptor signaling, receptor tyrosine kinase signaling, and depletion of internal calcium stores. TRPC3 expression is up-regulated in multiple rodent models of pathological cardiac hypertrophy, whereas TRPC5 expression is induced in failing human heart. We demonstrate that TRPC promotes cardiomyocyte hypertrophy through activation of calcineurin and its downstream effector, the nuclear factor of activated T cells transcription factor. These results define a novel role for TRPC channels in the control of cardiac growth, and suggest that a TRPC-derived pool of calcium contributes to selective activation of calcineurin in diseased heart.
Received for publication, June 9, 2006
, and in revised form, August 31, 2006.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
2 Supported by grants from the National Institutes of Health, The Donald W. Reynolds Clinical Cardiovascular Research Center, The Robert A. Welch Foundation, and the Texas Advanced Technology Program.
1 To whom correspondence may be addressed. Tel.: 303-464-5234; Fax: 303-410-6669; E-mail: erik.bush{at}myogen.com. 3 To whom correspondence may be addressed. Tel.: 303-533-1736; Fax: 303-410-6669; E-mail: timothy.mckinsey{at}myogen.com.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Chen, R. F. Crossland, M. M. Z. Noorani, and S. P. Marrelli
Inhibition of TRPC1/TRPC3 by PKG contributes to NO-mediated vasorelaxation
Am J Physiol Heart Circ Physiol,
July 1, 2009;
297(1):
H417 - H424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Prasad and G. Inesi
Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes
Am J Physiol Cell Physiol,
May 1, 2009;
296(5):
C992 - C1002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kiyonaka, K. Kato, M. Nishida, K. Mio, T. Numaga, Y. Sawaguchi, T. Yoshida, M. Wakamori, E. Mori, T. Numata, et al.
Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound
PNAS,
March 31, 2009;
106(13):
5400 - 5405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Schlondorff, D. del Camino, R. Carrasquillo, V. Lacey, and M. R. Pollak
TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription
Am J Physiol Cell Physiol,
March 1, 2009;
296(3):
C558 - C569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Abramowitz and L. Birnbaumer
Physiology and pathophysiology of canonical transient receptor potential channels
FASEB J,
February 1, 2009;
23(2):
297 - 328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Hongzhuan Sheng, Jianhua Zhu, Xiaohui Wu, and Jinan Zhang
Blockade of calcineurin reverses cardiac hypertrophy and induces the down-regulation of JNK mRNA expression in renovascular hypertensive rats
Journal of Renin-Angiotensin-Aldosterone System,
September 1, 2008;
9(3):
139 - 145.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Grubb, O. Vasilevski, H. Huynh, and E. A. Woodcock
The extreme C-terminal region of phospholipase C{beta}1 determines subcellular localization and function; the "b" splice variant mediates {alpha}1-adrenergic receptor responses in cardiomyocytes
FASEB J,
August 1, 2008;
22(8):
2768 - 2774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Alvarez, A. Coulombe, O. Cazorla, M. Ugur, J.-M. Rauzier, J. Magyar, E.-L. Mathieu, G. Boulay, R. Souto, P. Bideaux, et al.
ATP/UTP activate cation-permeable channels with TRPC3/7 properties in rat cardiomyocytes
Am J Physiol Heart Circ Physiol,
July 1, 2008;
295(1):
H21 - H28.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Niizeki, Y. Takeishi, T. Kitahara, T. Arimoto, M. Ishino, O. Bilim, S. Suzuki, T. Sasaki, O. Nakajima, R. A. Walsh, et al.
Diacylglycerol kinase-{varepsilon} restores cardiac dysfunction under chronic pressure overload: a new specific regulator of G{alpha}q signaling cascade
Am J Physiol Heart Circ Physiol,
July 1, 2008;
295(1):
H245 - H255.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tokudome, I. Kishimoto, T. Horio, Y. Arai, D. O. Schwenke, J. Hino, I. Okano, Y. Kawano, M. Kohno, M. Miyazato, et al.
Regulator of G-Protein Signaling Subtype 4 Mediates Antihypertrophic Effect of Locally Secreted Natriuretic Peptides in the Heart
Circulation,
May 6, 2008;
117(18):
2329 - 2339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dattilo, N. J. Penington, and K. Williams
Inhibition of TRPC5 Channels by Intracellular ATP
Mol. Pharmacol.,
January 1, 2008;
73(1):
42 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nishida, N. Onohara, Y. Sato, R. Suda, M. Ogushi, S. Tanabe, R. Inoue, Y. Mori, and H. Kurose
G{alpha}12/13-mediated Up-regulation of TRPC6 Negatively Regulates Endothelin-1-induced Cardiac Myofibroblast Formation and Collagen Synthesis through Nuclear Factor of Activated T Cells Activation
J. Biol. Chem.,
August 10, 2007;
282(32):
23117 - 23128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Fauconnier, J. T. Lanner, A. Sultan, S.-J. Zhang, A. Katz, J. D. Bruton, and H. Westerblad
Insulin potentiates TRPC3-mediated cation currents in normal but not in insulin-resistant mouse cardiomyocytes
Cardiovasc Res,
January 15, 2007;
73(2):
376 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|